Azimuth Capital Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
Sell
-77,720
Closed -$1.62M 282
2016
Q3
$1.62M Sell
77,720
-93,610
-55% -$1.95M 0.14% 166
2016
Q2
$4.61M Buy
171,330
+2,700
+2% +$72.6K 0.41% 88
2016
Q1
$4.57M Sell
168,630
-4,110
-2% -$111K 0.44% 86
2015
Q4
$5.02M Buy
172,740
+15,240
+10% +$443K 0.49% 77
2015
Q3
$4.27M Buy
157,500
+980
+0.6% +$26.6K 0.45% 80
2015
Q2
$4.29M Buy
156,520
+20,580
+15% +$564K 0.42% 86
2015
Q1
$3.63M Buy
135,940
+11,530
+9% +$308K 0.35% 97
2014
Q4
$2.63M Buy
124,410
+11,480
+10% +$243K 0.27% 123
2014
Q3
$2.69M Buy
112,930
+5,630
+5% +$134K 0.3% 106
2014
Q2
$2.48M Buy
107,300
+9,370
+10% +$216K 0.28% 116
2014
Q1
$2.24M Sell
97,930
-20
-0% -$456 0.27% 115
2013
Q4
$1.81M Buy
97,950
+9,300
+10% +$172K 0.22% 137
2013
Q3
$1.5M Hold
88,650
0.21% 141
2013
Q2
$1.37M Buy
+88,650
New +$1.37M 0.24% 127